Follow
Ezra Cohen
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
110162021
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
EEW Cohen, D Soulières, C Le Tourneau, J Dinis, L Licitra, MJ Ahn, ...
The Lancet 393 (10167), 156-167, 2019
14472019
Cabozantinib in progressive medullary thyroid cancer
R Elisei, MJ Schlumberger, SP Müller, P Schöffski, MS Brose, MH Shah, ...
Journal of clinical oncology 31 (29), 3639-3646, 2013
12582013
PI3Kγ is a molecular switch that controls immune suppression
MM Kaneda, KS Messer, N Ralainirina, H Li, CJ Leem, S Gorjestani, ...
Nature 539 (7629), 437-442, 2016
10812016
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck
EEW Cohen, F Rosen, WM Stadler, W Recant, K Stenson, D Huo, ...
Journal of clinical oncology 21 (10), 1980-1987, 2003
7732003
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study
EEW Cohen, LS Rosen, EE Vokes, MS Kies, AA Forastiere, FP Worden, ...
Journal of Clinical Oncology 26 (29), 4708-4713, 2008
7442008
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas
TY Seiwert, Z Zuo, MK Keck, A Khattri, CS Pedamallu, T Stricker, C Brown, ...
Clinical cancer research 21 (3), 632-641, 2015
6802015
American Cancer Society head and neck cancer survivorship care guideline
EEW Cohen, SJ LaMonte, NL Erb, KL Beckman, N Sadeghi, ...
CA: a cancer journal for clinicians 66 (3), 203-239, 2016
6382016
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer
R Kurzrock, SI Sherman, DW Ball, AA Forastiere, RB Cohen, R Mehra, ...
Journal of Clinical Oncology 29 (19), 2660-2666, 2011
6322011
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
EEW Cohen, RB Bell, CB Bifulco, B Burtness, ML Gillison, KJ Harrington, ...
Journal for immunotherapy of cancer 7, 1-31, 2019
5862019
Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer
EEW Cohen, TG Karrison, M Kocherginsky, J Mueller, R Egan, CH Huang, ...
Journal of clinical oncology 32 (25), 2735-2743, 2014
5652014
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum …
JPH Machiels, RI Haddad, J Fayette, LF Licitra, M Tahara, JB Vermorken, ...
The Lancet Oncology 16 (5), 583-594, 2015
470*2015
Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck
JSW Stewart, EEW Cohen, L Licitra, CML Van Herpen, C Khorprasert, ...
Journal of clinical oncology 27 (11), 1864-1871, 2009
4392009
Characterization of HPV and host genome interactions in primary head and neck cancers
M Parfenov, CS Pedamallu, N Gehlenborg, SS Freeman, L Danilova, ...
Proceedings of the National Academy of Sciences 111 (43), 15544-15549, 2014
4302014
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas
MP Rethman, W Carpenter, EEW Cohen, J Epstein, CA Evans, CM Flaitz, ...
The Journal of the American Dental Association 141 (5), 509-520, 2010
4262010
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised …
NY Lee, RL Ferris, A Psyrri, RI Haddad, M Tahara, J Bourhis, K Harrington, ...
The Lancet Oncology 22 (4), 450-462, 2021
3982021
Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes
MK Keck, Z Zuo, A Khattri, TP Stricker, CD Brown, M Imanguli, D Rieke, ...
Clinical cancer research 21 (4), 870-881, 2015
3912015
Vemurafenib in patients with BRAFV600E-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label …
MS Brose, ME Cabanillas, EEW Cohen, LJ Wirth, T Riehl, H Yue, ...
The lancet oncology 17 (9), 1272-1282, 2016
3672016
Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma
AG Sacco, EE Cohen
Journal of clinical oncology 33 (29), 3305-3313, 2015
3642015
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease
JK Salama, MD Hasselle, SJ Chmura, R Malik, N Mehta, KM Yenice, ...
Cancer 118 (11), 2962-2970, 2012
3602012
The system can't perform the operation now. Try again later.
Articles 1–20